The Kenya Medical Supplies Authority (KEMSA) has suffered a major legal setback after the High Court ordered the release of Sh1 billion from its bank accounts to settle a long-running dispute over the supply of HIV drugs.
The ruling follows a protracted courtroom battle between KEMSA and supplier UCL over a procurement deal involving fixed-dose antiretroviral (ARV) combinations used in Kenya’s HIV treatment programme.
Court Orders Release of Funds
In its decision, the High Court directed that Sh1 billion be lifted from KEMSA’s accounts to settle the outstanding payment owed to UCL. The supplier had moved to court after KEMSA declined to honour the contract, despite claims that it had fully delivered on its obligations.
The contested contract was initiated as an emergency procurement to address urgent gaps in the country’s HIV drug pipeline and guarantee uninterrupted access to life-saving medication for thousands of patients.
However, KEMSA later denied responsibility for the procurement agreement, arguing that it was not liable for the disputed payment — a defence the court ultimately rejected.
Implications for Kenya’s HIV Programme
The ruling has raised fresh concerns about governance and accountability within KEMSA, particularly given Kenya’s heavy reliance on consistent antiretroviral drug supplies.
Kenya operates one of the largest HIV treatment programmes in sub-Saharan Africa, with hundreds of thousands of patients dependent on uninterrupted access to ARVs. Analysts warn that prolonged procurement disputes could disrupt service delivery and erode public confidence in the health system.
The judgment also places additional financial strain on KEMSA, which has previously faced scrutiny over procurement practices and management of donor-funded medical supplies.
Renewed Pressure on Procurement Oversight
Health policy experts argue that the case underscores the urgent need for greater transparency and stricter oversight in public health procurement, especially for essential medicines funded through government and donor partnerships.
As Kenya continues efforts to safeguard continuity in HIV treatment services, the High Court ruling is expected to intensify calls for reforms aimed at strengthening accountability within key public health institutions.
